B
Biomemory
Provides biodigital data storage for large companies and administrations
About Biomemory
BioMemory is a groundbreaking startup that operates in the data storage industry, offering an innovative solution known as DNA Drives. The company has developed a unique technology that allows data to be stored on DNA, a medium that is not only ultra-durable but also environmentally friendly. This technology offers a storage density that is a million times higher than any Solid State Drive (SSD) or Magnetic Tape currently available in the market.
Read full description
BioMemory's target clients are likely to be businesses and organizations that require long-term, secure, and high-density data storage solutions. This could range from tech companies to research institutions, and even government agencies. The company operates in the broader tech industry, but more specifically in the data storage and management market.
The business model of BioMemory revolves around the production and sale of its DNA Drives. The company generates revenue by selling these drives to clients who need to store large amounts of data in a secure and sustainable manner. The DNA Drives are assembled from bio-sourced components, which means they use less energy and have no CO2 emissions. This not only makes them a more sustainable choice but also a cost-effective one in the long run, as they require no energetic input and are stable at ambient temperatures.
In conclusion, BioMemory is a pioneering startup that is leveraging the power of DNA to revolutionize the data storage industry. It offers a solution that is not only more durable and efficient but also more environmentally friendly than traditional storage methods.
At a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Paris, France
- Employees
- 78
- Open positions
- 6
- Dealroom signal
- 86.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Sustainable Development Goals, Climate Tech, Future of Computing, Memory and Storage, biotech medtech and e-health
- Technology
- Hardware, Big Data, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2024 | $18M | $72M | Bpifrance · Paris Business Angels · Adnexus · Sorbonne Venture | ↗ |
| SUPPORT PROGRAM✓Other financing | Sep 2024 | $0 | — | CDL-Paris | — |
Growth signals
Latest recorded traffic for Biomemory is 2.3K monthly website visits, up 91.7% over the last three months. Biomemory's team grew 13% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
EureKARE
Prunay Impact
Paris Business Angels
Series A5 investors entered at this stage
Crédit Mutuel Innovation
Bpifrance
Adnexus
Sorbonne Venture
Blast. Club
Other known investors7 additional known investors
CNRS Innovation
CDL-Paris
French National Centre for Scientific Research - CNRS
Sorbonne University
Agoranov
SATT LUTECH
Jean-David Benichou
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biomemory on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biomemory’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.